Skip to content

Getting a prescription

How to get Mounjaro

Mounjaro is tirzepatide approved for type 2 diabetes. It is not approved for weight loss, and prescribing it for that purpose is off-label — lawful, common, and the reason most weight-related claims against it are refused.

If weight management is the goal and there is no diabetes diagnosis, Zepbound is the same molecule with the matching approval. That is usually the product being looked for, whether or not it is the one being asked about.

178
GLP-1 clinics
29
States
123
Telehealth
54
License verified

What to know first

  • Mounjaro is approved for type 2 diabetes, not for weight loss. Prescribing it for weight is off-label.
  • Zepbound is the same molecule approved for chronic weight management, and it is the product a plan is far more likely to consider.
  • 178 clinics we checked name Mounjaro, and 123 of them offer telehealth visits.
  • A licensed clinician still has to evaluate you and write it. Off-label does not mean informal.

How to get Mounjaro prescribed

Identical to any tirzepatide prescription, with one conversation that is specific to this product and best had before money changes hands.

  1. 1. Evaluation

    Height, weight, and history, including whether you carry a type 2 diabetes or prediabetes diagnosis. That answer determines whether this product is on-label for you and how a claim will be read.

  2. 2. The off-label conversation

    If weight is the goal without a diabetes diagnosis, ask why Mounjaro rather than Zepbound. Supply is a legitimate answer; the question should still get a direct one.

  3. 3. Coverage expectations

    Set them before the prescription is written. A plan covering Mounjaro for diabetes will commonly refuse it for weight, and the pharmacy counter is an expensive place to find out.

  4. 4. Titration and follow-up

    Mounjaro and Zepbound do not share a dosing schedule, so switching later is not a straight substitution. Ask what follow-up costs and how a switch would be handled.

Mounjaro, Zepbound, or compounded tirzepatide?

One molecule, three positions. For weight care the difference is which one an insurer will read as appropriate.

Mounjaro

Approved for type 2 diabetes. Prescribed off-label for weight very widely. The medicine is not in question; the approval is, and it does not match a weight-management diagnosis.

Zepbound

The same molecule approved for chronic weight management, and separately for obstructive sleep apnea. The product normally sought when weight is the goal.

Compounded tirzepatide

Not an FDA-approved generic and not reviewed as a finished product. Common in cash-pay programs and outside any coverage pathway.

For how it works, its side effects, and how it compares with the alternatives, see the tirzepatide medication guide.

What does Mounjaro cost?

Brand cash pricing is high and the coverage that would offset it is exactly what the off-label question puts at risk. Only 92 of the 178 listings here publish a price.

The off-label penalty

A weight diagnosis on a Mounjaro prescription is the most common reason a claim is refused. Where a plan covers weight care it usually names the weight-indicated product.

A diabetes diagnosis changes the question

With type 2 diabetes documented, Mounjaro is on-label and coverage becomes an ordinary formulary matter.

Supply

Availability by dose has moved repeatedly. A program quoting a price should say what happens in a month when your dose is not available.

What the fee covers

Establish whether the monthly figure includes medication or only visits, and what the maintenance dose costs.

Six questions worth asking before paying

Sources: FDA Zepbound prescribing information · NIDDK, Prescription Medications to Treat Overweight & Obesity. Eligibility and prescribing decisions belong to a qualified healthcare professional. This page is informational and is not medical advice.